Health Economics & Outcomes Research Ltd, Cardiff (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients
